Form EFFECT Cyclacel Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 11, 2025 |
| Accession Number: | 0001641172-25-026154 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MicroAlgo Inc. Develops a Reconfigurable Simulation Technology of High-Precision, High-Throughput Scalable Quantum Algorithms
- In HelloNation, Physical Therapy Expert Vince Baylerian of Brighton, MI, Breaks Down Dizziness and Balance Problems
- BOXABL Announces First Phase 2 Order with Shelton Development for 203 Boxes in Texas
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
